Top compounds associated with response to TBC1D22B


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA birinapant CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA JW-480 CTRPv2 pan-cancer AAC 0.13 0.001
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.1 0.001
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV